MRM // 2022 Universal Registration Document

3

General information on the issuer and its share capital Management report for the financial year ended 31 December 2022

It will be proposed to the General Meeting of shareholders called to approve the financial statements for the financial year ended 31 December 2022, to renew the authorisations to buy back treasury shares and to cancel any shares acquired. 3.3 Employee shareholding In accordance with the provisions of Article L.225-102 of the French Commercial Code, we hereby inform you that the employee shareholding in the Company’s share capital on the last day of the 2022 financial year represented 0.05% of the share capital or 1,598 shares, resulting from the vesting on 29 May 2022 for their beneficiaries of free shares granted on 29 May 2019 under the 2019-01 Plan. In accordance with Articles L.225-184 and L.225-197-4 paragraph 1 of the French Commercial Code, we inform you that: • the Company has no stock-option plans; • a free share allocation plan was set up in the 2022 financial year for employees and the Chief Executive Officer of the Company.

The objectives mentioned above are presented without prejudice to the actual order of use of the buyback authorisation. During the 2022 financial year, the Company acquired 29,904 shares and sold 36,627. The average purchase price was €1.26 from 1 January 2022 to 19 April 2022 and €25.39 from 20 April to 31 December 2022. The average selling price was €1.29 from 1 January 2022 to 19 April 2022 and €26.32 from 20 April to 31 December 2022. These transactions were all carried out through the liquidity contract under the aforementioned first objective of the share buyback programme. There were no reallocations during the year. Trading costs amounted to €0. At the end of the financial year, the Company therefore held a total of 3,747 treasury shares representing 0.12% of the share capital and a nominal value of €74,940 allocated to the aforementioned first objective of the share buyback programme. These securities are entered as Company assets in its corporate financial statements, and deducted from equity in the consolidated financial statements. On 9 January 2023, the Company made an additional contribution of €50 thousand to the liquidity contract.

Information on the free share allocation plans in progress is detailed in the table below:

2022-1 Plan 2021-1 Plan 2020-1 Plan 2019-1 Plan

24 June 2021 29 May 2019 29 May 2019 29 May 2019 7 April 2022 1 April 2021 26 June 2020 29 May 2019

General Meeting date Board meeting date

Total number of shares awarded, of which the number awarded to:

3,762 2,067

3,836 (1) 2,329 (1)

2,184 (1)

1,610 (1)

Corporate officers

0

0

Vesting date

7 April 2025 1 April 2024 26 June 2023 29 May 2022 7 April 2025 1 April 2024 26 June 2023 29 May 2022

Lockup period end date Performance conditions (2)

Yes

Yes

N/A

N/A

Number of shares vested as of 31 December 2022 Aggregate number of cancelled or lapsed shares Performance shares remaining as of 31 December 2022

0 0

0 0

0 0

1,598

12

3,762

3,836

2,187

0

(1) Number of shares granted adjusted by the Board of directors on 24 February 2022 to take into account the reverse stock split effective 20 April 2022. (2) Presence and performance conditions.

M.R.M. 2022 UNIVERSAL REGISTRATION DOCUMENT

66